Silvia G. Priori
University of Pavia
551 Papers
7.5K Citations
Silvia G. Priori is an academic researcher from University of Pavia. The author has contributed to research in topics: Medicine & Long QT syndrome. The author has an hindex of 140, co-authored 515 publications. Previous affiliations of Silvia G. Priori include Carlos III Health Institute & Hannover Medical School.
Chat about Author
Papers
Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology
Domenico Corrado,Antonio Pelliccia,Hans Bjornstad,Luc Vanhees,Alessandro Biffi,Mats Börjesson,Nicole M. Panhuyzen-Goedkoop,Asterios Deligiannis,Erik Ekker Solberg,Dorian Dugmore,Klaus Peter Mellwig,Deodato Assanelli,Pietro Delise,Frank van-Buuren,Aris Anastasakis,Hein Heidbuchel,Ellen Hoffmann,Robert Fagard,Silvia G. Priori,Cristina Basso,Eloisa Arbustini,Carina Blomström-Lundqvist,William J. McKenna,Gaetano Thiene +23 more
TL;DR: In this paper, the authors present the consensus statement of the Study Group on Sports Cardiology of the Working Group on Cardiac Rehabilitation and Exercise Physiology and the working group on Myocardial and Pericardial diseases of the European Society of Cardiology, which comprises cardiovascular specialists and other physicians from different European countries with extensive clinical experience with young competitive athletes, as well as with pathological substrates of sudden death.
Proposed diagnostic criteria for the Brugada syndrome: consensus report.
Arthur A.M. Wilde,Charles Antzelevitch,Martin Borggrefe,Josep Brugada,Ramon Brugada,Pedro Brugada,Domenico Corrado,Richard N.W. Hauer,Robert S. Kass,Koonlawee Nademanee,Silvia G. Priori,Jeffrey A. Towbin +11 more
TL;DR: A number of ambiguities exist concerning the diagnosis of Brugada syndrome as mentioned in this paper, which is characterized by ST-segment elevation in right precordial leads (V1 to V3) that is unrelated to ischemia, electrolyte disturbances, or obvious structural heart disease.
875
American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines
Barry J. Maron,William J. McKenna,Gordon K. Danielson,Lukas Kappenberger,Horst J. Kuhn,Christine E. Seidman,Pravin M. Shah,William H. Spencer,Paolo Spirito,Folkert J. Ten Cate,E. Douglas Wigle,Robert A. Vogel,Jonathan Abrams,Eric R. Bates,Bruce R. Brodie,Peter G. Danias,Gabriel Gregoratos,Mark A. Hlatky,Judith S. Hochman,Sanjiv Kaul,Robert C. Lichtenberg,Jonathan R. Lindner,Robert A. O'Rourke,Gerald M. Pohost,Richard S. Schofield,Cynthia M. Tracy,William L. Winters,Werner Klein,Silvia G. Priori,Angeles Alonso-Garcia,Carina Blomström-Lundqvist,Guy De Backer,Jaap W. Deckers,Markus Flather,Jaromír Hradec,Ali Oto,Alexander Parkhomenko,Sigmund Silber,Adam Torbicki +38 more
TL;DR: The reader should view the CECD as the best attempt of the ACC and the ESC to inform and guide clinical practice in areas where rigorous evidence may not yet be available or the evidence to date is not widely accepted.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Valentin Fuster,Lars Rydén,David S. Cannom,Harry J.G.M. Crijns,Anne B. Curtis,Kenneth A. Ellenbogen,Jonathan L. Halperin,Jean-Yves Le Heuzey,G. Neal Kay,James E. Lowe,S. Bertil Olsson,Eric N. Prystowsky,Juan Tamargo,Samuel Wann,Sidney C. Smith,Alice K. Jacobs,Cynthia D. Adams,Jeffery L. Anderson,Elliott M. Antman,Sharon A. Hunt,Rick A. Nishimura,Joseph P. Ornato,Richard L. Page,Barbara Riegel,Silvia G. Priori,Jean Jacques Blanc,Andrzej Budaj,A. John Camm,Veronica Dean,Jaap W. Deckers,Catherine Despres,Kenneth Dickstein,John Lekakis,Keith McGregor,Marco Metra,João Morais,Ady Osterspey,José Luis Zamorano +37 more
Low Penetrance in the Long-QT Syndrome Clinical Impact
TL;DR: It is no longer acceptable to exclude LQTS among family members of definitely affected patients on purely clinical grounds, and it now appears appropriate to perform molecular screening in allfamily members of genotyped patients.
854